6. Molycorp, Inc. (MCP, Earnings, Analysts, Financials): Focuses on the production and sale of rare earth oxides from stockpiled feedstocks in the western hemisphere. Market cap at $1.22B, most recent closing price at $8.81. Net institutional purchases in the current quarter at 10.7M shares, which represents about 11.75% of the company’s float of 91.05M shares. Over the last six months, insiders were net buyers of 7,107,150 shares, which represents about 7.81% of the company’s 91.05M share float.
7. Pendrell Corporation (PCO, Earnings, Analysts, Financials): Through its wholly-owned subsidiary, Pendrell Technologies, Inc., provides corporate intellectual property solutions and litigation insights to Fortune 500 companies and technology firms worldwide. Market cap at $278.84M, most recent closing price at $1.07. Net institutional purchases in the current quarter at 43.0M shares, which represents about 26.45% of the company’s float of 162.60M shares. Over the last six months, insiders were net buyers of 2,500,000 shares, which represents about 1.54% of the company’s 162.60M share float.
8. Repros Therapeutics Inc. (RPRX, Earnings, Analysts, Financials): Market cap at $250.98M, most recent closing price at $14.66. Net institutional purchases in the current quarter at 2.6M shares, which represents about 20.44% of the company’s float of 12.72M shares. Over the last six months, insiders were net buyers of 557,500 shares, which represents about 4.38% of the company’s 12.72M share float. 9. Tenet Healthcare Corp. (THC, Earnings, Analysts, Financials): Operates acute care hospitals and related health care facilities. Market cap at $3.08B, most recent closing price at $28.95. Net institutional purchases in the current quarter at 10.2M shares, which represents about 11.25% of the company’s float of 90.63M shares. Over the last six months, insiders were net buyers of 3,000,000 shares, which represents about 3.31% of the company’s 90.63M share float.
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
